Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Tessmer James F
Relationship:   VP, Finance & Accounting
City:   The Woodlands
State:   TX
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   71,766    

Indirect Shares

  0      
Direct Value   $139,944    

Indirect Value

  $0      
Total Shares   71,766      
Total Value   $139,944      


Lexicon Pharmaceuticals Inc
 $139,944 Lexicon Pharmaceuticals Inc
 $139,944
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Lexicon Pharmaceuticals Inc LXRX VP, Finance & Accounting 2021-03-15 71,766 0    Premium*  
* Premium Members only  

Records found :    38         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
LXRX Lexicon Pharmaceuticals I... VP, Finance & AcctgOfficer   •       –      –    2008-04-29 3 IO $0.00 $0 D/D 0 1,700 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Acctg   •       –      –    2009-02-12 4 A $0.00 $0 D/D 24,100 25,800 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       –      –    2011-02-23 4 A $0.00 $0 D/D 6,906 25,585 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       –      –    2012-02-28 4 OE $0.00 $0 D/D 7,500 30,969 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2013-01-31 4 OE $0.00 $0 D/D 13,200 41,870 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2013-02-28 4 OE $0.00 $0 D/D 14,250 51,810 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2014-02-28 4 OE $0.00 $0 D/D 20,250 68,253 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2015-03-02 4 OE $0.00 $0 D/D 29,625 91,266 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2016-02-29 4 OE $0.00 $0 D/D 5,828 17,572 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2017-02-28 4 OE $0.00 $0 D/D 6,939 22,885 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2018-02-28 4 OE $0.00 $0 D/D 7,353 27,448 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2019-02-28 4 OE $0.00 $0 D/D 10,226 35,869 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-02-28 4 OE $0.00 $0 D/D 16,396 59,764 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-04-22 4 A $0.00 $0 D/D 13,262 69,124 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2021-02-28 4 OE $0.00 $0 D/D 28,316 93,443 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2015-03-02 4 D $0.94 $8,499 D/D (9,041) 82,225 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2019-08-02 4 B $1.14 $11,400 D/D 10,000 43,368 2.74 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       –      –    2012-02-28 4 D $1.78 $4,092 D/D (2,299) 28,670 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       –      –    2011-02-23 4 D $1.81 $3,830 D/D (2,116) 23,469 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       –      –    2010-02-12 4 D $1.91 $7,514 D/D (3,934) 18,679 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2014-02-28 4 D $1.92 $12,695 D/D (6,612) 61,641 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-04-22 4 D $1.96 $7,834 D/D (3,997) 65,127 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2013-02-28 4 D $1.98 $7,538 D/D (3,807) 48,003 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2013-01-31 4 D $2.11 $9,094 D/D (4,310) 37,560 0 -
LXRX Lexicon Pharmaceuticals I... VP, Finance & Accounting   •       •      –    2020-02-28 4 D $2.77 $10,809 D/D (3,902) 55,862 0 -

  38  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed